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Introduction
Cell size must be tightly controlled to ensure function and sur­
vival (Jorgensen and Tyers, 2004; Turner et al., 2012). Control 
of cell size in dividing cells is achieved via cell size checkpoints, 
which delay key cell cycle transitions until sufficient growth has 
occurred. Despite their name, it is uncertain whether cell size 
checkpoints monitor a parameter linked to cell size, such as vol­
ume or surface area, or whether they monitor parameters linked 
to growth or biosynthetic capacity. Discovery of checkpoint sig­
nals that link the cell cycle to cell growth is thus an essential 
step toward understanding how cell size is controlled.
Cell size checkpoints operate at entry into the cell cycle in 
G1 and again at mitosis. The mitotic checkpoint works through 
the Wee1 kinase, which delays mitosis via inhibitory phosphory­
lation of Cdk1 (Nurse, 1975; Gould and Nurse, 1989). Wee1 is 
a dose­dependent regulator of cell size. Thus, loss of Wee1 in 
fission yeast causes premature entry into mitosis at a reduced 
cell size, whereas increased activity of Wee1 causes delayed 
entry into mitosis and increased cell size (Nurse, 1975; Russell 
and Nurse, 1987). The signals that connect Cdk1 inhibitory phos­
phorylation to cell growth are poorly understood.
The G1 cell size checkpoint is best understood in bud­
ding  yeast.  Cell  division  in  budding  yeast  is  asymmetric, 
yielding a large mother cell and a small daughter cell. The ob­
servation that the small daughter cell spends more time under­
going growth in G1 provided early evidence for the existence 
of cell size checkpoints (Hartwell and Unger, 1977; Johnston 
et al., 1977). It also focused attention on the mechanisms that 
control cell cycle entry and how they might be linked to cell 
size. The key molecular event that drives cell cycle entry is   
activation of Cdk1 by G1 cyclins (Richardson et al., 1989; 
Cross, 1990). There are three G1 cyclins that bind and activate 
Cdk1 in budding yeast, called Cln1, Cln2, and Cln3 (Hadwiger 
et al., 1989; Richardson et al., 1989). Transcription of CLN3 is 
initiated in early G1, and the Cln3–Cdk1 complex helps trig­
ger  transcription  of  the  late  G1  cyclins  CLN1  and  CLN2 
(Dirick and Nasmyth, 1991). Cln1/2 drive growth of a new 
daughter cell, which marks commitment to a new round of 
cell division (Richardson et al., 1989; Cross, 1990; McCusker 
et al., 2007).
C
ell size checkpoints ensure that passage through 
G1 and mitosis occurs only when sufficient growth 
has  occurred.  The  mechanisms  by  which  these 
checkpoints work are largely unknown. PP2A associated 
with the Rts1 regulatory subunit (PP2A
Rts1) is required for 
cell size control in budding yeast, but the relevant targets 
are unknown. In this paper, we used quantitative pro-
teome-wide mass spectrometry to identify proteins con-
trolled by PP2A
Rts1. This revealed that PP2A
Rts1 controls the 
two key checkpoint pathways thought to regulate the cell 
cycle in response to cell growth. To investigate the role of 
PP2A
Rts1 in these pathways, we focused on the Ace2 tran-
scription factor, which is thought to delay cell cycle entry 
by repressing transcription of the G1 cyclin CLN3. Diverse 
experiments suggest that PP2A
Rts1 promotes cell cycle entry 
by inhibiting the repressor functions of Ace2. We hypoth-
esize that control of Ace2 by PP2A
Rts1 plays a role in mech-
anisms that link G1 cyclin accumulation to cell growth.
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in rts1 cells. Because we previously found that PP2A
Rts1 is   
required for control of G1 cyclin transcription, we were par­
ticularly interested in G1 targets of PP2A
Rts1 (Artiles et al., 
2009). We therefore synchronized wild­type and rts1 cells and   
collected samples for MS 10 min before the G1 cyclin Cln2 ap­
peared, which is when the decision to initiate G1 cyclin tran­
scription is made. Proteolytic peptides from each strain were 
covalently modified by reductive dimethylation to generate light 
(wild type) and heavy (rts1) stable isotope­labeled pools. 
After combining, phosphopeptides were enriched by strong cat­
ion exchange (SCX) followed by TiO2 affinity chromatography 
and identified via liquid chromatography (LC)–MS/MS (Fig. 1 A; 
Villén and Gygi, 2008; Kettenbach and Gerber, 2011).
The heavy to light ratios of phosphorylated peptides in 
rts1 cells versus wild­type cells were log2 transformed. Thus, 
positive values indicate increased phosphorylation in rts1, 
whereas  negative  values  indicate  decreased  phosphorylation.   
A parallel analysis of sample­matched unphosphorylated peptides 
was used to generate protein abundance ratios that were used to 
correct for differences in protein abundance between the two 
samples (Table S1). Three biological replicates of the experi­
ment were performed, which allowed calculation of average 
log2 ratios and SDs for most peptides. The complete dataset ap­
pears in Tables S1–S3. Table S1 lists all protein quantification 
data, Table S2 lists all identified phosphorylation sites along 
with quantitative data, and Table S3 provides detailed informa­
tion for each of the 78,204 phosphopeptides that were detected.
A total of 10,807 sites were identified on 2,066 proteins. 
Of these, 9,255 sites on 1,937 proteins could be quantified. We 
focused on sites that were quantified in at least two of three bio­
logical replicates. This high­quality set includes 5,159 sites on 
1,544 proteins (Fig. 1 B). Note that the analysis is not compre­
hensive; many peptides are not detected as a result of poor ion­
ization, loss during chromatography, or low abundance.
Relative peptide abundances were calculated as the ratio 
of corresponding heavy and light peptide pairs as determined 
from their extracted ion chromatograms. A visual representa­
tion of this is shown for a single phosphopeptide in Fig. S1. For 
each phosphorylation site, we calculated an average ratio from 
all quantified peptides harboring each site. We used a twofold 
SD from the mean, representing a 2.5­fold change in either 
direction, to define significant changes in phosphorylation 
(Fig. 1 C). At this threshold, we identified 241 sites on 156 proteins 
that were hyperphosphorylated in rts1 cells (Table S4). We 
observed fewer sites whose phosphorylation decreased: 59 sites 
on 45 proteins (Table S5).
PP2A
Rts1 is required for normal regulation 
of key effectors of cell size control
Table S4 lists proteins that underwent significant hyperphos­
phorylation in rts1 cells. It is likely that additional regulated 
sites whose ratios fell below our cutoff exist in the data. Several 
of the regulated proteins are linked to known roles of PP2A
Rts1. 
For example, PP2A
Rts1 controls Kin4 in the spindle orientation 
checkpoint (Chan and Amon, 2009). A site in Kin4, serine 351, 
was up­regulated nearly threefold in rts1 cells. PP2A
Rts1 also 
controls chromosome cohesion (Yu and Koshland, 2007). Here, 
Early evidence pointed to Cln3 as playing a critical role in 
cell size control. Loss of CLN3 causes a prolonged delay in 
entry into the cell cycle. Cell growth continues during the delay, 
leading to increased cell size (Cross, 1988). Conversely, over­
expression of CLN3 causes premature entry into the cell cycle at 
a reduced cell size (Cross, 1988; Nash et al., 1988). Together, 
these observations suggested that Cln3, like Wee1, is a critical 
dose­dependent regulator of cell size (Cross, 1988; Nash et al., 
1988). In this view, cell size in G1 phase could be controlled by 
mechanisms that link production of active Cln3/Cdk1 to attain­
ment of a critical cell size. Several observations, however, indi­
cate that this kind of model is too simplistic. First, cln3 cells 
still show size­dependent entry into the cell cycle (Di Talia et al., 
2009; Ferrezuelo et al., 2012). Thus, although cln3 cells are 
significantly larger than wild­type cells, small unbudded cln3 
cells spend more time undergoing growth in G1 than larger un­
budded cells. In addition, cln3 cells undergo normal nutrient 
modulation of cell size, in which cells reduce their size in re­
sponse to poor nutrients (Jorgensen et al., 2004). Together, these 
observations indicate that modulation of Cln3 alone is insuffi­
cient to explain cell size control in G1.
Although Wee1 and G1 cyclins clearly play roles in cell size 
control, it is unlikely that they are involved in the mechanisms that 
determine size. Both are capable of accelerating or delaying the 
cell cycle in a dose­dependent manner, which suggests that they re­
spond to checkpoint signals that determine the duration of growth 
at specific phases of the cell cycle. Thus, they appear to be down­
stream effectors of a global mechanism of cell size control. The na­
ture of this global mechanism has remained deeply mysterious.
We recently discovered that a specific form of PP2A (protein 
phosphatase 2A) is required for cell size control (Artiles et al., 
2009). Canonical PP2A is a trimeric complex composed of a cata­
lytic subunit, a scaffolding subunit, and a regulatory subunit (Zhao 
et al., 1997; Janssens and Goris, 2001). In budding yeast, there are 
two regulatory subunits, referred to as Rts1 and Cdc55, that form 
two distinct complexes: PP2A
Rts1 and PP2A
Cdc55 (Zhao et al., 1997). 
We previously discovered that rts1 causes increased cell size and 
a failure to undergo nutrient modulation of cell size (Artiles et al., 
2009). In addition, rts1 causes a prolonged delay in transcription 
of the G1 cyclin Cln2, a prolonged delay in mitosis, and defects in 
regulatory phosphorylation of Wee1 (Artiles et al., 2009; Harvey   
et al., 2011). Together, these observations suggest that PP2A
Rts1 
functions in both G1 and mitotic cell size checkpoints. However, 
the targets of PP2A
Rts1 that mediate these functions were unknown. 
Here, we used proteome­wide mass spectrometry (MS) to identify 
targets of PP2A
Rts1. This revealed that PP2A
Rts1 controls key ele­
ments of both cell size checkpoints, which suggests that it func­
tions in the mysterious cell size control mechanisms that send 
signals to G1 cyclins and Wee1. We further discovered that PP2A
Rts1 
controls the transcription factor Ace2, which likely contributes to 
mechanisms that link CLN3 transcription to cell growth.
Results
A proteomic screen for targets of PP2A
Rts1
To identify targets of PP2A
Rts1, we used quantitative phosphopro­
teomics to search for proteins that become hyperphosphorylated 361 PP2A
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The analysis also identified proteins involved in cell size 
control during mitosis. For example, the inhibitory site on Cdk1 
that is phosphorylated by Wee1 showed one of the most dra­
matic  increases,  being  up­regulated  >25­fold  in  rts1  cells. 
Moreover, Swe1, the budding yeast homologue of Wee1, was 
hyperphosphorylated on multiple sites that were previously 
found to be required for its activation (Harvey et al., 2005, 
2011). This is consistent with our previous finding that rts1 
causes Swe1 to accumulate in a hyperphosphorylated active 
form, which is the likely cause of a prolonged mitotic delay 
(Harvey et al., 2011). We also identified three related kinases 
that are required for Swe1 inactivation: Hsl1, Gin4, and Kcc4 
(Ma et al., 1996; Barral et al., 1999; McMillan et al., 1999; 
Longtine et al., 2000). Loss of these kinases can cause delayed 
entry into mitosis and severe cell size defects (Altman and 
Kellogg, 1997; Barral et al., 1999). Loss of these kinases also 
causes Swe1 to accumulate in a hyperphosphorylated active 
form, similar to rts1 (Shulewitz et al., 1999; Okuzaki et al., 2003). 
Together, these observations suggest that PP2A
Rts1 controls 
Swe1 via Hsl1, Gin4, and Kcc4. The fission yeast homologues 
of Hsl1, Gin4, and Kcc4 are required for nutrient modulation of 
cell size (Young and Fantes, 1987; Belenguer et al., 1997).
The MS data show that PP2A
Rts1 controls both of the 
known targets of cell size control: G1 cyclin expression and 
we identified two proteins involved in chromosome cohesion as 
new targets of PP2A
Rts1­dependent regulation: Pds1 and Ulp2.
We focused on targets of PP2A
Rts1 that could provide clues 
to its role in cell size control. The analysis identified multiple 
proteins involved in cell size control in G1, including three fac­
tors that control G1 cyclin transcription: Swi4, Swi5, and Ace2. 
Swi4 is a transcriptional activator of the late G1 cyclins CLN1 
and CLN2 (Nasmyth and Dirick, 1991; Ogas et al., 1991). Swi5 
and Ace2 are related factors that control transcription of genes 
expressed in late mitosis and early G1 (Dohrmann et al., 1992; 
Doolin et al., 2001). Ace2 is a repressor of CLN3 transcription, 
whereas  Swi5  controls  transcription  of  the  G1  cyclin  Pcl2, 
which activates Pho85 and acts redundantly with Cln1/2 to pro­
mote bud emergence (Aerne et al., 1998; Laabs et al., 2003; 
Moffat and Andrews, 2004; Di Talia et al., 2009). Bck2, an up­
stream regulator of CLN1/2 transcription, was hyperphosphory­
lated in one of the biological replicates (Table S2; Di Como et al., 
1995; Bastajian et al., 2013). Thus, PP2A
Rts1 appears to control 
transcription of all of the key G1 cyclins. The analysis also 
identified Ydj1, which is thought to control Cln3 localization 
and stability (Yaglom et al., 1996; Vergés et al., 2007). Loss of 
Ace2, Swi4, or Ydj1 causes defects in cell size control (Breeden 
and Mikesell, 1991; Caplan and Douglas, 1991; Dohrmann et al., 
1992; Di Talia et al., 2009; Ferrezuelo et al., 2012).
Figure 1.  A phosphoproteomic screen for proteins regulated by PP2A
Rts1. (A) A schematic summary of the approach used to search for targets of PP2A
Rts1. 
(B) A total of 9,255 sites were quantified in three biological replicates. The overlap of sites quantified from each replicate is shown. (C) The log2 distribution 
of 5,159 sites quantified in at least two replicates. The area outside the dotted lines indicates sites that change by two SDs or greater. The log2 distribution 
of the 2,702 quantified proteins is shown in the inset. Expt., experiment; WT, wild type.JCB • VOLUME 204 • NUMBER 3 • 2014   362 
again at 50 min as cells entered the next mitosis. Ace2 was dra­
matically hyperphosphorylated in rts1 cells relative to wild­
type cells (Fig. 2 C). In addition, Ace2 dephosphorylation and 
destruction of Clb2 were delayed by 20 min in rts1 cells, 
which indicated that PP2A
Rts1 is required for normal mitotic 
inhibitory phosphorylation of Cdk1. Thus, PP2A
Rts1 may be a 
component of global cell size control mechanisms. Here, we fo­
cused on the Ace2 transcription factor. Table 1 shows data for 
all identified Ace2 phosphorylation sites, which includes four 
significantly regulated sites: S122, S253, S709, and T713. Ace2 
is asymmetrically segregated into the nuclei of small daughter 
cells, where it is thought to delay cell cycle entry via inhibition 
of CLN3 transcription (Laabs et al., 2003; Di Talia et al., 2009). 
However, regulation of Ace2 has not been linked to signals that 
relay information about cell growth or size. Ace2 also functions 
as a transcriptional activator for genes involved in septation 
(Dohrmann et al., 1992).
Loss of PP2A
Rts1 causes defects in 
phosphorylation of the Ace2  
transcription factor
To extend the MS data, we assayed Ace2 phosphorylation in 
synchronized  wild­type  and  rts1  cells.  Phosphorylation  of 
Ace2 causes an electrophoretic mobility shift that can be as­
sayed  by Western  blotting  (Sbia  et  al.,  2008;  Mazanka  and 
Weiss, 2010). We first assayed Ace2 after release from a G1   
arrest imposed by mating pheromone. The mitotic cyclin Clb2 
was assayed in the same samples as a marker for cell cycle pro­
gression. In wild­type cells, Ace2 was present at low levels 
early in the cell cycle and began to accumulate and undergo ex­
tensive hyperphosphorylation as cells entered mitosis, consistent 
with previous studies that Ace2 is phosphorylated by mitotic 
Cdk1 (Fig. 2 A; O’Conalláin et al., 1999; Sbia et al., 2008; 
Mazanka and Weiss, 2010). In rts1 cells, the mitotic hyper­
phosphorylation of Ace2 was delayed by 20 min, consistent 
with a previously reported G1 delay in rts1 cells (Artiles et al., 
2009). To compare differences in Ace2 phosphorylation during 
G1, we loaded the initial time points from Fig. 2 A in an inter­
calated manner (Fig. 2 B). This revealed that a fraction of Ace2 
was hyperphosphorylated in rts1 cells during G1.
We also assayed Ace2 phosphorylation and Clb2 levels 
after release from a metaphase arrest. Ace2 was phosphorylated 
in metaphase­arrested wild­type cells and was dephosphory­
lated as cells exited mitosis (Fig. 2 C). Ace2 underwent a tran­
sient phosphorylation at 30 min and became phosphorylated 
Table 1.  Ace2 phosphorylation sites
Site Local sequence No. identified  
peptides
No. quantified  
peptides
No. replicates  
quantified
Average ratio SD
S122 SHKRGLSGTAIFG 2 2 2 2.51 0.72
T135 FLGHNKTLSISSL 1 1 1 2.41 ND
S137 GHNKTLSISSLQQ 2 0 0 ND ND
S140 KTLSISSLQQSIL 3 0 0 ND ND
T245 KLVSGATNSNSKP 6 2 1 2.44 ND
S249 GATNSNSKPGSPV 6 5 2 0.93 0.02
S253 SNSKPGSPVILKT 8 7 2 1.43 0.73
S709 KKSLLDSPHDTSP 9 9 3 1.54 0.29
T713 LDSPHDTSPVKET 9 7 2 1.62 0.24
S714 DSPHDTSPVKETI 4 4 2 1.27 0.05
The table shows all identified and quantified phosphosites in Ace2. The phosphorylated residue is shown in bold in the context of its flanking sequence. Six sites 
were identified in two out of three biological replicates, and out of those six, four showed increased phosphorylation above the log2 threshold: S122, S253, 
S709, and T713.
Figure 2.  The Ace2 transcription factor is hyperphosphorylated in rts1 cells. 
(A) Cells were released from a G1 arrest, and the behavior of Ace2 and Clb2 
was assayed by Western blotting. (B) The same samples shown in Fig. 2 B 
were loaded in an intercalated manner to visualize differences between wild­
type and rts1 cells. (C) Cells were released from a metaphase arrest, and the 
behavior of Ace2 and Clb2 was assayed by Western blotting.363 PP2A
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family that plays roles in bud growth and mitotic exit (Mazanka 
et al., 2008). During late mitosis, Cbk1 is asymmetrically local­
ized to the daughter nucleus, where it phosphorylates Ace2 on 
several sites that inhibit nuclear export (Colman­Lerner et al., 
2001; Weiss et al., 2002; Mazanka et al., 2008). Cbk1 could 
therefore inhibit nuclear export of Ace2 to delay CLN3 tran­
scription in newborn daughter cells. One of the high confidence 
Ace2 sites corresponds to a Cbk1 consensus site (S122) that is 
phosphorylated in vitro and in vivo in a Cbk1­dependent man­
ner (Mazanka et al., 2008). Western blotting with a phosphospe­
cific antibody (Mazanka and Weiss, 2010) demonstrated that this 
site is hyperphosphorylated in rts1 cells (Fig. 3 B). Thus, Cbk1 
is likely responsible for hyperphosphorylating at least one site on 
Ace2 in rts1 cells. However, most of the sites that were hyper­
phosphorylated in rts1 cells do not correspond to Cbk1 consen­
sus sites, which suggests that multiple kinases may be involved.
To further test the roles of Cdk1 and Cbk1, we reconsti­
tuted phosphorylation of Ace2 in vitro. Cdk1 caused a shift in 
the electrophoretic mobility of Ace2 that was similar to the 
Cdk1­dependent shift observed in vivo (Fig. 3, A and C). Cbk1 
also shifted the electrophoretic mobility of Ace2, but the extent 
of the shift appeared to be less than the shift caused by rts1  
in vivo (Fig. 3 C). We considered the possibility that efficient 
phosphorylation of Ace2 by Cbk1 requires priming by Cdk1; 
however, Cdk1 did not appear to enhance Cbk1 phosphoryla­
tion of Ace2 in vitro (Fig. 3 C).
Because there was the possibility that the reconstituted re­
actions lacked key factors necessary for efficient phosphoryla­
tion of Ace2 by Cbk1, we also tested the role of Cbk1 in vivo. 
We attempted to use an analogue­sensitive allele of Cbk1 to test 
whether hyperphosphorylation of Ace2 after release from a mitotic 
exit. Because we did not observe a drop in Ace2 levels as cells 
traversed G1 after release from a metaphase arrest (Fig. 2 C), it 
is likely that low levels of Ace2 after release from a G1 arrest 
(Fig. 2 A) is caused by the prolonged arrest, rather than by a 
mechanism that degrades Ace2 during G1 in every cell cycle.
Cbk1 contributes to hyperphosphorylation 
of Ace2 in rts1 cells
We next searched for the kinase that hyperphosphorylates Ace2 
in rts1 cells. Cdk1 is thought to phosphorylate Ace2 during 
mitosis to block its nuclear import (O’Conalláin et al., 1999; 
Sbia et al., 2008; Mazanka and Weiss, 2010). If Cdk1 and PP2A
Rts1 
acted on the same sites, one would predict that dephosphory­
lation of Ace2 would fail to occur or would occur more slowly 
when Cdk1 was inactivated in rts1 cells. To test this, we used 
an analogue­sensitive allele of CDK1 (cdk1-as1) that can be 
rapidly  and  specifically  inhibited  by  addition  of  1NM­PP1 
(Bishop et al., 2000). Ace2 phosphorylation was assayed after 
addition of 1NM­PP1 to rapidly growing wild type, cdk1-as1, 
rts1,  and  cdk1-as1  rts1  cells.  Inhibition  of  Cdk1  caused 
rapid dephosphorylation of Ace2 in both cdk1-as1 and cdk1-as1 
rts1 cells (Fig. 3 A). This suggests that Cdk1 and PP2A
Rts1  
do not act on the same sites but does not rule out a more com­
plex model in which PP2A
Rts1 acts redundantly with another 
phosphatase on Cdk1 target sites. None of the four high con­
fidence hyperphosphorylated sites on Ace2 correspond to the   
optimal mitotic Cdk1 consensus site (S/TPXXR/K), although 
three of the four correspond to the minimal Cdk1 consensus   
site (S/TP).
Ace2 is also phosphorylated by Cbk1, a member of the 
NDR/LATS (nuclear Dbf2­related/large tumor suppressor) kinase 
Figure 3.  Multiple kinases contribute to hy-
perphosphorylation  of  Ace2  in  rts1  cells.  
(A) Samples were taken at the indicated times 
after addition of 1NM­PP1 to log phase cells, 
and phosphorylation of Ace2 was assayed by 
Western blotting. (B) Ace2­3×HA was immuno­
precipitated from wild­type, rts1, or cbk1 cells 
and probed with anti­Ace2 antibody or with an 
antibody that recognizes phosphorylated S122. 
Ace2­3×HA was immunoprecipitated from the 
cbk1 cells as a control to demonstrate that 
the phosphospecific antibody recognizes a site 
phosphorylated by Cbk1. (C) Kinase reactions 
containing affinity purified Ace2­3×HA, Cbk1­
3×HA, and Cdk1/Clb2­3×HA in the indicated 
combinations were initiated by addition of ATP. 
Ace2­3×HA phosphorylation was assayed by 
Western blotting with the anti­HA mouse mono­
clonal antibody. (D) Cells were grown to log 
phase at room temperature, and Ace2 phos­
phorylation was assayed by Western blotting. 
The arrow indicates a hyperphosphorylated 
form of Ace2.JCB • VOLUME 204 • NUMBER 3 • 2014   364 
transcription. We first used genetics to test this model. If PP2A
Rts1 
is an inhibitor of Ace2, ace2 could rescue temperature­dependent 
growth defects caused by rts1. To test this, we assayed rate   
of  colony  formation  in  wild­type,  rts1,  ace2,  and  rts1 
ace2 cells at 30 and 37°C. We found that ace2 partially res­
cued the temperature­dependent growth defect caused by rts1 
(Fig. 4 A). Because ace2 causes a cell separation defect, colo­
nies could appear larger because they start from a clump of cells 
rather than a single cell. We therefore used a Bioscreen appara­
tus to measure rates of growth of each strain. This confirmed 
that ace2 partially rescued the slow growth phenotype of rts1 
cells at both 30 and 34°C (Fig. 4 B).
We also discovered that overexpression of Ace2 from the 
GAL1 promoter was lethal in rts1 cells, consistent with the 
idea that PP2A
Rts1 inhibits transcriptional repressor functions of 
Ace2 (Fig. 4 C). The lethality of ACE2 overexpression in rts1 
suggests that hyperactive Ace2 must have targets in addition to 
CLN3 because deletion of CLN3 alone is not lethal.
arrest depended on Cbk1 activity. However, for unknown rea­
sons, rts1 cbk1-as cells expressed very low levels of Ace2 
when arrested in mitosis, so we were unable to obtain a clear re­
sult. Instead, we assayed hyperphosphorylation of Ace2 in log 
phase wild­type, rts1, cbk1, and rts1 cbk1 cells. The ma­
jority of Ace2 phosphorylation that can be detected in log phase 
cells is caused by mitotic Cdk1; however, a hyperphosphory­
lated form of Ace2 could be faintly detected in both rts1 and 
rts1 cbk1 cells (Fig. 3 D, arrow). This observation provides 
further evidence that Cbk1 cannot be solely responsible for hy­
perphosphorylation of Ace2 in rts1 cells.
PP2A
Rts1 is likely a negative regulator  
of Ace2
Because rts1 causes a prolonged G1 delay, we hypothesized 
that PP2A
Rts1 inhibits repressor functions of Ace2. In this model, 
inactivation of PP2A
Rts1 causes Ace2 to become hyperphosphory­
lated, which makes it hyperactive as a repressor of CLN3 
Figure 4.  Genetic analysis suggests that PP2A
Rts1 is a negative regulator of Ace2. (A) A series of fivefold dilutions of cells were grown on YPD media at 
30 or 37°C. (B) Eight independent colonies grown overnight at 23°C were diluted into fresh medium and grown in a Bioscreen C apparatus. The average 
growth of the eight cultures was plotted, with SDs shown. (C) A series of fivefold dilutions of cells were grown at 30°C on YEP media containing either 
dextrose or galactose.365 PP2A
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Overexpression of CLN3 partially rescues 
cell size defects caused by rts1
Loss of RTS1 or CLN3 causes cells to become abnormally large 
(Cross, 1988; Artiles et al., 2009). We hypothesized that hyper­
active Ace2 in rts1 cells causes failure to produce normal   
levels of Cln3, leading to increased cell size. To test this, we 
overexpressed CLN3 from the GAL1 promoter in rts1 cells. 
This reduced the size of rts1 cells to nearly the same size as 
wild­type cells, consistent with the hypothesis (Fig. 5). A pre­
vious study found that CLN3 overexpression causes cells to be­
come significantly smaller than wild­type cells (Fig. 5; Tyers 
et al., 1992). Thus, GAL1-CLN3 does not cause the same size 
reduction in wild­type and rts1 cells, which indicates that cell 
size defects caused by rts1 are not caused solely by a failure to 
produce normal levels of Cln3. This is consistent with the dis­
covery that PP2A
Rts1 controls diverse pathways required for cell 
size control.
PP2A
Rts1 is required for normal control  
of Cln3 protein and mRNA levels
To further test the hypothesis that PP2A
Rts1 controls production 
of Cln3 via Ace2, we assayed CLN3 mRNA accumulation in 
wild­type, rts1, ace2, and rts1 ace2 cells after release 
from a G1 arrest. CLN3 mRNA levels were assayed both by 
quantitative RT­PCR (qRT­PCR) and by Northern blotting, 
which gave similar results. Accumulation of Cln3­6×HA pro­
tein was assayed in identical time courses, and the mitotic cyclin 
Clb2 was assayed in the same samples to provide a marker for cell 
cycle progression.
In wild­type cells, CLN3 mRNA and protein peaked in G1 
at 20–30 min (Figs. 6, A–C; and S2). There was a second peak 
of CLN3 mRNA and protein later in the cell cycle that appeared 
at the same time as peak levels of the mitotic cyclin Clb2, indi­
cating that Cln3 is produced in mitosis (Fig. 6, A–D). In rts1 
cells, accumulation of CLN3 mRNA and protein was reduced 
and delayed (Figs. 6, A–C; and S2). The defect in CLN3 mRNA 
accumulation caused by rts1 at 20 min showed a statistically 
significant  rescue  by  ace2  (Fig.  6  B).  In  addition,  ace2  
Figure 5.  Overexpression of CLN3 partially rescues the cell size defects 
caused by rts1. Cells were grown to log phase in media containing 2% 
galactose,  and  cell  size  distributions  were  determined  using  a  Coulter 
counter. Each plot represents the average of three independent biologi­
cal replicates in which three independent samples were analyzed for 
each strain.
Figure 6.  PP2A
Rts1 is required for normal control of CLN3 mRNA and 
protein levels in cells released from a G1 arrest. (A–D) Wild­type, rts1, 
ace2, and rts1 ace2 cells were released from G1 arrest at 30°C, 
and the behavior of CLN3 mRNA was assayed by Northern blotting (A) 
or qRT­PCR (B). Independent samples were probed for Cln3­6×HA (C) and 
Clb2 (D) by Western blotting. The Cln3­6×HA and Clb2 Western blots 
were from the same samples to allow direct comparison of the timing of 
cell cycle events. Loading controls for the Northern blot and the Western   
blots are shown in Fig. S2. Error bars in B indicate the SDs of three biologi­
cal replicates.JCB • VOLUME 204 • NUMBER 3 • 2014   366 
Figure 7.  PP2A
Rts1 is required for normal control of CLN3 mRNA and protein 
levels in cells released from a metaphase arrest. (A–C) GAL-CDC20, GAL-
CDC20 rts1, GAL-CDC20 ace2, and GAL-CDC20 ace2 rts1 cells were 
released from a metaphase arrest at 30°C, and samples were analyzed by 
qRT­PCR (A). Independent samples were probed for Cln3­6×HA (B) and Clb2 
(C) by Western blotting. The Cln3­6×HA and Clb2 Western blots were from 
advanced the peak of Cln3 protein early in the cell cycle in 
rts1 cells, consistent with a rescue of CLN3 mRNA levels. 
However, defects in CLN3 mRNA accumulation that occurred 
later in the cell cycle (time points 50–100 min) were not rescued 
by ace2 (Fig. 6, A–C).
We performed similar experiments in cells released from 
a metaphase arrest. In wild­type cells, CLN3 mRNA and protein 
were present at the metaphase arrest and then increased as Clb2 
levels declined, reaching a peak 20 min after release from the 
arrest (Fig. 7, A–C). Cln3 protein was present throughout most 
of G1, decreased before mitosis, and then accumulated again 
during the second mitosis. The decline in CLN3 mRNA and 
protein at 30 min was correlated with hyperphosphorylation of 
Ace2, consistent with a role for Ace2 hyperphosphorylation in 
repression of CLN3 transcription (Figs. 2 C and 7, A and B, 
compare wild­type samples). In rts1 cells, destruction of Clb2 
was delayed, indicating a delay in exit from mitosis, and CLN3 
mRNA and protein failed to accumulate to normal levels as 
cells exited mitosis (Fig. 7, A–C). Defects in CLN3 mRNA   
accumulation in rts1 cells were not rescued by ace2 (Fig. 7, 
A and B).
Together, these observations show that ace2 may rescue 
some, but not all, defects in CLN3 mRNA accumulation caused 
by rts1. A possible explanation is that PP2A
Rts1 controls an ad­
ditional repressor of CLN3 transcription. The only other known 
repressor of CLN3 transcription is Yox1 (Pramila et al., 2002; 
Bastajian et al., 2013). The MS analysis identified a hyperphos­
phorylated Yox1 peptide in rts1 cells with high confidence in 
one of the biological replicates (Table S3). In addition, yox1 
improved the growth rate of rts1 ace2 cells at 34°C (Fig. 7 D). 
Finally, rts1 increased the toxicity caused by expression of 
YOX1 from the GAL1 promoter (Fig. 7 E). PP2A
Rts1 may there­
fore control multiple repressors of CLN3 transcription.
PP2A
Rts1 is required for normal control of 
transcriptional activator functions of Ace2
In addition to its repressor functions, Ace2 is a transcriptional 
activator for genes involved in cell separation, including CTS1 
(Dohrmann et al., 1992). To test whether PP2A
Rts1 controls tran­
scriptional  activator  functions  of Ace2,  we  assayed  CTS1 
mRNA levels in wild­type, rts1, ace2, and rts1 ace2  
cells after release from a G1 arrest (Fig. 8). Levels of CTS1 
mRNA showed a significant increase in rts1 cells that was   
dependent on ACE2. Thus, Ace2 is hyperactive as a transcrip­
tional activator in rts1 cells.
PP2A
Rts1 is required for normal binding of 
Ash1 to the CLN3 promoter
Ace2 is thought to collaborate with Ash1 to repress CLN3 tran­
scription (Di Talia et al., 2009). Like Ace2, Ash1 is asymmetri­
cally segregated into the daughter cell at the end of cell division 
the same samples to allow direct comparison of the timing of cell cycle events. 
(D) Cell growth rate was analyzed using a Bioscreen C apparatus. (E) A se­
ries of 10­fold dilutions of cells were grown at 25°C on YEP media containing 
either dextrose or galactose. Error bars in A indicate the SDs of three biologi­
cal replicates. Error bars in D indicate SDs of four independent cultures.
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were taken to assay Ace2 phosphorylation and levels of CLN3 
mRNA and protein as the cells underwent growth and entry into 
the cell cycle. We also measured cell size as a function of time 
to monitor cell growth and the fraction of cells undergoing bud 
emergence to determine when cells enter the cell division cycle. 
We used Northern blotting to assay CLN3 mRNA levels because 
qRT­PCR requires normalization to an internal standard RNA, 
which could undergo significant changes as cells grow. By using 
Northern blotting to probe the same fraction of total RNA at 
each time point, we could assay levels of CLN3 mRNA per cell.
The small newborn daughter cells underwent continuous 
growth and initiated bud emergence at 130 min (Fig. 10, A and 
B). Ace2 was hyperphosphorylated in the small unbudded cells 
and underwent gradual dephosphorylation (Fig. 10 C). Maximal 
dephosphorylation of Ace2 occurred at 70–80 min. Cln3 was 
first detectable at 10 min and then accumulated gradually, reach­
ing peak levels around the time of maximal Ace2 dephos­
phorylation (Fig. 10 C). Thus, Ace2 dephosphorylation and Cln3 
protein accumulation occurred gradually during growth and 
were correlated. CLN3 mRNA accumulated gradually during 
growth, similar to Cln3 protein (Fig. 10 D). We consistently ob­
served a transient increase in CLN3 mRNA at 5 min, and Cln3 
protein began to accumulate shortly thereafter. This burst of 
CLN3 mRNA was not correlated with Ace2 phosphorylation.
As expected, the mitotic cyclin Clb2 was not detectable, 
which indicates that phosphorylation of Ace2 in this context 
was not caused by mitotic Cdk1 activity. It was not possible to 
isolate unbudded rts1 cells because of their severe cell size 
defects: centrifugal elutriation yielded a mixture of budded and 
unbudded cells that were of similar size.
Discussion
Identification of PP2A
Rts1 targets by 
proteome-wide MS
To identify targets of PP2A
Rts1­dependent regulation, we used 
quantitative proteome­wide MS to search for proteins that un­
dergo changes in phosphorylation in rts1 cells. Proteome­wide 
MS should prove to be a powerful tool for identifying phospha­
tase targets because one searches for proteins that undergo hy­
perphosphorylation, which is unlikely to be a result of indirect 
or toxic effects caused by inactivation of the phosphatase.
The analysis identified 156 proteins that undergo signifi­
cant hyperphosphorylation when PP2A
Rts1 is inactivated. These 
likely include direct targets of PP2A
Rts1 but also appear to delin­
eate entire pathways regulated by PP2A
Rts1. For example, sev­
eral components of a pathway that regulates mitosis via Cdk1 
inhibitory  phosphorylation  were  identified.  In  this  pathway, 
three related kinases called Gin4, Hsl1, and Kcc4 promote entry 
into mitosis by inactivating Swe1. Gin4 and Hsl1 are controlled 
by the septins, which were also identified as potential targets of 
PP2A
Rts1­dependent regulation (Table S2). Previous work found 
that rts1 causes a mitotic delay and defects in Swe1 phosphory­
lation;  however,  the  underlying  mechanisms  were  unknown. 
The MS data suggest that PP2A
Rts1 regulates mitosis via a path­
way that includes the septins, Gin4/Hsl1/Kcc4, and Swe1.
(Bobola et al., 1996). Chromatin immunoprecipitation (ChIP) 
experiments have shown that Ace2 and Ash1 bind to the CLN3 
promoter (Di Talia et al., 2009). To further investigate regula­
tion of CLN3 transcription by PP2A
Rts1, we assayed binding of 
Ace2 and Ash1 to the CLN3 promoter. Loss of Rts1 did not 
cause significant effects on binding of Ace2 to the CLN3 pro­
moter; however, binding of Ash1 was significantly increased 
(Fig. 9, A and B). In addition, binding of Ace2 was dependent 
on Ash1, and binding of Ash1 was strongly dependent on Ace2 
(Fig. 9, C and D). These findings suggest that hyperphosphory­
lation of Ace2 causes increased recruitment of Ash1, leading to 
transcriptional repression.
Ace2 is hyperphosphorylated in small 
unbudded daughter cells
The preceding experiments show that Ace2 is hyperphosphory­
lated in rts1 cells, which likely activates it to repress transcrip­
tion  of  CLN3. We  next  investigated  regulation  of Ace2  in 
wild­type cells. It is thought that Ace2 causes a G1 delay in 
small daughter cells by repressing CLN3 transcription (Laabs et al., 
2003; Di Talia et al., 2009). However, the signals that control 
the duration of the delay are unknown. The discovery that 
PP2A
Rts1 controls Ace2 suggested that it could play a role in de­
termining the duration of the G1 delay. We reasoned that one 
way to test this would be to monitor Ace2 hyperphosphoryla­
tion, as well as levels of CLN3 mRNA and protein, during G1 in 
newborn daughter cells. If PP2A
Rts1 plays a role in enforcing a 
G1  delay, Ace2  should  be  hyperphosphorylated  in  newborn 
daughter cells and dephosphorylation of Ace2 should be corre­
lated with accumulation of Cln3.
Cells synchronized via a cell cycle arrest cannot be used 
to study events that occur in small newborn daughter cells be­
cause cells grow during the arrest. To circumvent this problem, 
we used centrifugal elutriation to isolate small daughter cells. 
To enrich for very small daughter cells, the cells were grown in 
media containing a poor carbon source before elutriation. After 
isolation, the cells were released into rich media, and samples 
Figure 8.  PP2A
Rts1 is required for normal control of CTS1 mRNA levels. 
Wild­type, rts1, ace2, and rts1 ace2 cells were released from a G1 
arrest at 30°C, and the behavior of CTS1 mRNA was assayed by qRT­PCR. 
Error bars indicate the SDs of three biological replicates.JCB • VOLUME 204 • NUMBER 3 • 2014   368 
mechanisms that signal to Swe1 and the G1 cyclins have proven 
remarkably difficult to discover.
In previous work, we found that PP2A
Rts1 is required for 
normal control of cell size as well as nutrient modulation of cell 
size (Artiles et al., 2009). Here, we discovered that PP2A
Rts1 
regulates pathways that control both Swe1 and G1 cyclins.   
Together, these observations suggest the possibility that PP2A
Rts1  
is a component of the enigmatic cell size control mechanisms 
that signal to Swe1 and G1 cyclins.
In G1 phase, PP2A
Rts1 controls phosphorylation of two 
key transcription factors for G1 cyclins: Ace2 and Swi4. Ace2 is 
a repressor of CLN3 transcription (Laabs et al., 2003; Di Talia 
et al., 2009), whereas Swi4 is a transcriptional activator for late 
G1 cyclins CLN1 and CLN2 (Nasmyth and Dirick, 1991; Ogas 
et al., 1991). Because Cln3 appears first and helps promote tran­
scription of CLN1 and CLN2, it was initially thought that size 
control in G1 works through CLN3. However, although cln3 
cells are abnormally large, they still show size­dependent entry 
into the cell cycle and nutrient modulation of cell size, which 
In addition to identifying targets of PP2A
Rts1­dependent 
regulation, the MS identified 10,807 phosphorylation sites on 
2,066 proteins. These sites significantly expand phosphoryla­
tion site data in budding yeast. Nevertheless, it must be kept in 
mind that proteome­wide MS is not comprehensive. Thus, little 
can be inferred from the absence of proteins or sites in the data. 
In addition, the analysis generally does not provide sufficient 
sequence coverage to warrant mutagenesis of identified sites to 
test their functions. Rather, further site mapping must be per­
formed using purified proteins to yield a more comprehensive 
identification of sites.
PP2A
Rts1 as a master regulator of cell size 
control pathways
Swe1 and the G1 cyclins play important roles in mechanisms 
that control cell size. Both serve as downstream effectors of cell 
size control mechanisms that accelerate or delay the cell cycle 
to allow more or less time for cell growth. The cell size control 
Figure 9.  Loss of PP2A
Rts1 causes increased binding of Ash1 to the CLN3 promoter. ChIP experiments were performed using Ace2­Myc, Ash1­Myc, or un­
tagged control strains. Transcription factor binding was measured for two regions of the CLN3 promoter, CLN3­A (1,026 to 830) and CLN3­B (853 
to 642), in distance from the ATG. Data from at least three replicates were analyzed by an unpaired two­tailed t test to test for statistically significant 
differences. Error bars indicate SDs.369 PP2A
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regulators of Swe1 causes defects in cell size (Ma et al., 1996; 
Shulewitz et al., 1999; Sreenivasan and Kellogg, 1999; Longtine 
et al., 2000; Jorgensen et al., 2002; Harvey and Kellogg, 2003; 
Kellogg, 2003; Harvey et al., 2005). Moreover, nutrients almost 
certainly modulate cell size at both G1 and mitosis. Classic experi­
ments performed over 30 years ago discovered that daughter 
cells exit mitosis at a smaller size in poor nutrients (Johnston 
et al., 1977). More recent work has confirmed that the smallest 
cells in a population of cells growing in poor nutrients are 
smaller than the smallest cells in rich nutrients, which can only 
occur if daughter cells exit mitosis at a smaller size (see, for ex­
ample, Fig. 3 A in Jorgensen et al. [2004] or Fig. 11 A in Artiles 
shows that cell size control in G1 cannot work solely through 
CLN3 (Nasmyth and Dirick, 1991; Jorgensen et al., 2004; Di 
Talia et al., 2009; Ferrezuelo et al., 2012). The discovery that 
PP2A
Rts1 controls both Ace2 and Swi4 suggests that a common 
mechanism could link transcription of both early and late G1 
cyclins to cell size or growth. Thus, size dependent entry into 
the cell cycle in cln3 cells could work through PP2A
Rts1­ and 
Swi4­dependent control of CLN1 and CLN2 transcription.
In mitosis, PP2A
Rts1 regulates a pathway that controls in­
hibitory phosphorylation of Cdk1. Although much emphasis 
has been placed on control of cell size at G1 in budding yeast, it 
is likely that size is also controlled in mitosis. Loss of Swe1 or 
Figure 10.  Ace2 is hyperphosphorylated in 
small unbudded daughter cells. Small unbud­
ded cells in G1 were isolated by centrifugal 
elutriation  and  released  into  YPD  medium 
at  25°C.  (A)  Cell  size  was  analyzed  using 
a  Coulter  counter  and  plotted  as  a  function 
of time. (B) The percentage of budded cells 
was plotted as a function of time. (C) Ace2 
phosphorylation and Cln3­6×HA levels were 
assayed by Western blotting. All samples in 
A–C were taken from the same time course. 
(D) Samples from an independent time course 
were probed for CLN3 mRNA. The same mem­
brane was probed for ACT1 mRNA as a load­
ing control. (E) A model for PP2A
Rts1­dependent 
mechanisms  that  control  CLN3  transcription 
via Ace2. For simplicity, mitotic regulation of 
Ace2 by Cdk1 is not shown in the model.JCB • VOLUME 204 • NUMBER 3 • 2014   370 
gene has an unusually large 5 untranslated region and is subject 
to complex regulation (Polymenis and Schmidt, 1997).
What is the kinase that hyperphosphorylates Ace2 in rts1 
cells?  Previous  work  found  that Ace2  is  phosphorylated  by 
Cbk1, which drives asymmetric localization of Ace2 into daugh­
ter cell nuclei (Mazanka et al., 2008). There is also evidence 
that Cbk1 controls additional Ace2 functions (Mazanka et al., 
2008). The MS identified a Cbk1 target site (S122), and Western 
blotting with a phosphospecific antibody confirmed that the site 
is hyperphosphorylated in rts1 cells. However, purified Cbk1 
did not appear to be capable of phosphorylating Ace2 in vitro to 
the same extent observed in vivo in rts1 cells. In addition, the 
MS identified numerous sites that have not been attributed to 
Cbk1. Thus, it is likely that at least one additional kinase regu­
lates Ace2. We found no clear evidence that hyperphosphoryla­
tion of Ace2 in rts1 cells is caused by Cdk1. Moreover, the 
rts1 phenotype is not consistent with hyperphosphorylation   
of Ace2 on mitotic Cdk1 sites because previous work suggests 
that this should lead to constitutive cytoplasmic localization of 
Ace2, where it could not repress CLN3 transcription (O’Conalláin 
et al., 1999; Sbia et al., 2008).
PP2A
Rts1 could act directly on Ace2, or it could act further 
upstream to inhibit a kinase or activate a phosphatase that acts 
on Ace2. We found that purified PP2A
Rts1 was not able to de­
phosphorylate Ace2; however, we could not demonstrate that 
the PP2A
Rts1 was active, so the experiment was inconclusive.
PP2A
Rts1 may contribute to gradual Cln3 
accumulation during growth of small cells
Cln3 has been difficult to detect by Western blotting so its be­
havior during the cell cycle has been little characterized. We 
used highly sensitive Western blotting techniques to gain an un­
precedented view of Cln3 protein during the cell cycle. This re­
vealed that Cln3 shows significant periodic oscillations. One 
peak of Cln3 occurs in G1, as expected for a G1 cyclin, and a 
second peak occurs as the mitotic cyclin Clb2 reaches peak lev­
els. The functions of Cln3 during mitosis are unknown.
We also assayed Cln3 and Ace2 during growth of new­
born daughter cells. An important hypothesis for cell size con­
trol suggests that Cln3 levels are proportional to cell growth or 
size and that cell cycle entry is triggered when Cln3 levels reach 
a threshold (Jorgensen and Tyers, 2004; Turner et al., 2012). 
However, Cln3 has never been assayed in growing newborn 
daughter cells to test this model. We found that Cln3 was ini­
tially absent in newborn daughter cells and then accumulated 
gradually during growth. Cln3 reached peak levels at 90 min, 
and bud emergence began 40 min later. The striking correlation 
between Cln3 protein levels and cell growth is consistent with 
the Cln3 threshold model. The delay between peak Cln3 levels 
and bud emergence may correspond to a previously described 
size­independent delay in G1 that occurs before bud emergence 
(Di Talia et al., 2007, 2009). Alternatively, the delay may reflect 
additional size­dependent mechanisms that regulate the activity 
or localization of Cln3 (Vergés et al., 2007). Mechanisms that re­
strain the ability of CLN3 to trigger cell cycle entry during early 
daughter cell growth may play a role in setting a size threshold.
et al. [2009]). This suggests the existence of a mechanism that 
drives progression through mitosis at a smaller bud size when 
cells are growing in poor nutrients. Because PP2A
Rts1 is required 
for nutrient modulation of cell size and regulates mitosis, it may 
be an essential component of this mechanism. PP2A
Rts1 appears 
to control mitosis via the related kinases Gin4, Hsl1, and Kcc4. 
Fission yeast homologues of these kinases (Cdr1 and Cdr2)   
are required for nutrient modulation of cell size at entry into 
mitosis, which suggests a conserved mechanism (Young and 
Fantes, 1987).
PP2A
Rts1 controls G1 cyclin transcription 
via the Ace2 transcription factor
We focused on Ace2 as a starting point for characterizing pro­
teins controlled by PP2A
Rts1. Ace2 is thought to delay cell cycle 
entry in small daughter cells via repression of CLN3 transcrip­
tion (Colman­Lerner et al., 2001; Laabs et al., 2003). The sig­
nals that control the length of the Ace2­dependent delay could 
control cell size but have been largely unknown. Our analysis 
suggests that PP2A
Rts1 controls Ace2 and likely influences the 
duration of G1 and cell size.
Diverse experiments support a model in which hyperphos­
phorylated Ace2 is active as a repressor of CLN3 transcription 
and  that  PP2A
Rts1  dephosphorylates Ace2  to  promote  CLN3 
transcription (Fig. 10 E). In rts1 cells, Ace2 was hyperphos­
phorylated, which correlated with decreased CLN3 mRNA and 
protein. In wild­type cells, there was a decrease in CLN3 mRNA 
and protein 30 min after release from metaphase arrest that cor­
related with Ace2 hyperphosphorylation. Finally, in small un­
budded cells undergoing growth, dephosphorylation of Ace2 
occurred gradually and was correlated with gradually increas­
ing Cln3 protein levels.
Genetic analysis provided additional support for the model: 
overexpression of ACE2 was lethal in rts1 cells, and ace2 
partially rescued the reduced growth rate of rts1 cells at ele­
vated temperatures. In addition, ace2 rescued defects in CLN3 
mRNA levels in rts1 cells early in the cell cycle. However, 
ace2 did not cause increased CLN3 mRNA levels in wild­type 
cells, and it did not rescue reduced levels of CLN3 mRNA in 
rts1 cells exiting mitosis. There are several potential explana­
tions for these observations. First, previous work suggests that 
Ace2  represses  CLN3  transcription  only  in  small  unbudded 
daughter cells; however, we were not able to test effects of rts1 
and ace2 upon CLN3 transcription in small daughter cells for 
two reasons. First, small daughter cells grow during cell cycle 
arrests and are therefore lost in synchronized cells. Second, 
ace2 and rts1 cause cell clumping or size defects that pre­
clude isolation of small daughter cells by centrifugal elutriation. 
Thus, we could not analyze the effects of rts1 and ace2 in 
the context most likely to show strong effects. Another consid­
eration is that PP2A
Rts1 could also activate factors that promote 
CLN3 transcription, in which case inactivation of the repressor 
would not be sufficient to rescue CLN3 mRNA levels in rts1 
cells. Finally, PP2A
Rts1 could regulate multiple repressors of 
CLN3 transcription. Consistent with this, we found evidence 
that PP2A
Rts1 controls Yox1, another repressor of CLN3 tran­
scription (Pramila et al., 2002; Bastajian et al., 2013). The CLN3 371 PP2A
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that Ace2 phosphorylation is proportional to growth suggests 
that it may respond to a proportional checkpoint signal. More­
over, the central role of PP2A
Rts1 in control of both Ace2 phos­
phorylation and cell size suggests that it could be responsible 
for generating or relaying a proportional checkpoint signal to 
Ace2, thereby ensuring that Cln3 levels are proportional to 
growth. PP2A
Rts1 could also play a role in setting the threshold. 
In this case, poor nutrients could regulate PP2A
Rts1 to lower the 
threshold, thereby allowing cells to go through the cell cycle at 
a reduced cell size. This kind of model could explain the puz­
zling observation that cells growing in poor nutrients enter the 
Ace2 was hyperphosphorylated in newborn daughter cells 
and underwent gradual dephosphorylation during cell growth, 
reaching maximal dephosphorylation at approximately the same 
time that Cln3 protein reached peak levels. This observation 
suggests the possibility that the extent of Ace2 dephosphoryla­
tion could help set the level of CLN3 transcription.
Cell size checkpoints must translate a parameter related to 
growth into a proportional checkpoint signal that can be read by 
downstream components to determine when sufficient growth 
has occurred. The nature of the proportional checkpoint signal 
is one of the central enigmas of cell size control. The discovery 
Table 2.  Strains used in this study
Strain MAT Genotype Reference or source
DK186 a bar1 Altman and Kellogg, 1997
DK351 a bar1 cdk1::cdk1-as1 Bishop et al., 2000
DK647 a bar1 rts1::kanMX6 Artiles et al., 2009
DK751 a bar1 CLN2-3×HA::LEU2 rts1::kanMX6 Artiles et al., 2009
DK968 a bar1 cdk1::cdk1-as1 rts1::HIS Bishop et al., 2000
DK1307 a bar1 CLN2-3×HA::LEU2 rts1::HIS Artiles et al., 2009
DK1907 a bar1 CLN2-3×HA::LEU2 rts1::HIS ace2::kanMX4 This study
DK1908 a bar1 CLN2-3×HA::LEU2 ace2::kanMX4 This study
DK1929 a bar1 CLN2-3×HA::LEU2 GAL1-ACE2::HIS5 This study
DK1930 a bar1 CLN2-3×HA::LEU2 GAL1-ACE2::HIS5 rts1::kanMX6 This study
DK2010 a bar1 pDK93A [GAL1-CLN3::URA] This study
DK2011 a bar1 pDK93A [GAL1-CLN3::URA] rts1::kanMX4 This study
DK2017 a bar1 CLN3-6×HA::HIS This study
DK2019 a bar1 CLN3-6×HA::HIS rts1::kanMX4 This study
DK2049 a bar1 CLN3-6×HA::HIS rts1::kanMX4 ace2::hphNT1 This study
DK2053 a bar1 CLN2-3×HA::LEU GAL1-YOX1::HIS This study
DK2054 a bar1 CLN2-3×HA::LEU GAL1-YOX1::HIS rts1::kanMX4 This study
DK2055 a bar1 CLN3-6×HA::HIS ace2::natMX4 This study
DK2056 a bar1 GAL1-CDC20::NatNT2 CLN3-6×HA::HIS This study
DK2057 a bar1 GAL1-CDC20::NatNT2 CLN3-6×HA::HIS rts1::kanMX4 This study
DK2058 a bar1 GAL1-CDC20::NatNT2 CLN3-6×HA::HIS rts1::kanMX4 ace2::hphNT1 This study
DK2093 a bar1 cbk1::HIS This study
DK2136 a bar1 GAL1-CDC20::NatNT2 CLN3-6×HA::HIS ace2::kanMX4 This study
DK2149 a bar1 ACE2-GFP::klTRP rts1::kanMX4 This study
DK2171 a bar1 cbk1::HIS rts1::kanMX4 This study
DK2490 a bar1 ACE2-3×HA::kanMX6 cbk1::HIS This study
DY150 a Thomas and Rothstein, 1989
DY151  Thomas and Rothstein, 1989
DY3924  ace2::HIS3 lys2 This study
DY5923 a ACE2-MYC(13)::kanMX This study
DY8309 a ASH1-MYC(13)::kanMX Takahata et al., 2011
DY9719 a ash1::TRP1 lys2 met15 This study
DY10788 a GAL1-CDC20::ADE2 lys2 Sbia et al., 2008
DY15549 a GAL1-CDC20::ADE2 lys2 ace2::HIS3 This study
DY15723  rts1::kanMX lys2 This study
DY15729  ace2::HIS3 rts1::kanMX6 lys2 met15 This study
DY15995 a GAL1-CDC20::ADE2 lys2 rts1::kanMX lys2 This study
DY15996 a GAL1-CDC20::ADE2 lys2 rts1::kanMX ace2::HIS3 lys2 This study
DY16269 a ACE2-MYC(13)::kanMX rts1::hphMX4 This study
DY16273 a ASH1-MYC(13)::kanMX rts1::hphMX4 lys2 This study
DY17134 a GAL1-CDC20::ADE2 yox1::natMX This study
DY17236 a GAL1-CDC20::ADE2 yox1::natMX ace2::HIS3 This study
DY17240 a GAL1-CDC20::ADE2 yox1::natMX rts1::kanMX This study
DY17242 a GAL1-CDC20::ADE2 yox1::natMX rts1::kanMX ace2::HIS This study
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buffer). The columns were washed with 6 ml of 1% FA, and the peptides 
were eluted with 1 ml of 70% acetonitrile (ACN) and 1% FA. Equal 
amounts of wild­type (light) and rts1 (heavy) peptides were combined 
and dried in a SpeedVac (Savant).
Phosphopeptide enrichment by SCX/TiO2
Phosphopeptides were enriched using a modified version of the two­step, 
SCX–immobilized metal affinity chromatography/TiO2 protocol using step 
elution from self­packed solid­phase extraction SCX chromatography car­
tridges as previously described with some changes (Villén and Gygi, 
2008; Dephoure and Gygi, 2011). Peptides were resuspended in 1 ml 
SCX buffer A (7 mM KH2PO4, pH 2.65, and 30% ACN) and loaded onto 
preequilibrated syringe­barrel columns packed with 500 mg of 20­µm, 
300­Å PolySULFOETHYL A resin (PolyLC). Peptides were eluted by the se­
quential addition of 3 ml SCX buffer A containing increasing concentra­
tions of KCl. 12 fractions were collected after elution with 0 (flow through), 
10, 20, 30, 40, 50, 60, 70, 80, 90, 100, and 200 mM KCl. All fractions 
were frozen in liquid nitrogen, lyophilized, resuspended in 1 ml of 1% FA, 
and desalted on 50­mg Sep­Paks. Peptides were eluted with 500 µl of 70% 
ACN and 1% FA. 5% of each fraction was taken off for protein abundance 
analysis. The remaining peptides were dried in a SpeedVac. TiO2 enrich­
ment was performed by either of two protocols. For replicate one, peptides 
from fractions 8–11 were pooled after desalting (fraction 12 was not used 
for phosphopeptide analysis). Dried peptides were resuspended in 50 µl of 
wash/binding buffer (30% ACN, 1% FA, and 70 mM glutamic acid) and 
incubated with 500 µg of Titansphere TiO2 beads (GL Sciences) with vigor­
ous shaking for 60 min at room temperature. The beads were washed 
three times with 200 µl of wash/binding buffer and once with 1% FA. 
Phosphopeptides were eluted in two steps by sequential treatments with   
50 µl of 0.5­M KH2PO4, pH 7.5. The eluates were acidified by the addition 
of FA to 1% final concentration, desalted on Stage tips (Rappsilber et al., 
2003), and dried in a SpeedVac. Eight fractions corresponding to 0, 10, 
20, 30, 40, 50, 60, and the pooled 70–100 mM KCl steps were analyzed 
by LC­MS/MS.
SCX for peptides from replicates 2 and 3 was performed as for set 
1, but 11 fractions were taken with steps of 0, 10, 20, 30, 40, 50, 60, 
70, 80, 90, and 200 mM KCl. Fractions 9–11 were pooled before TiO2 
enrichment. TiO2 phosphopeptide enrichment was performed using a mod­
ified protocol (Kettenbach and Gerber, 2011) using 2 mg TiO2 resin for 
each fraction and a wash/binding buffer composed of 50% ACN and   
2 M lactic acid.
MS
Phosphopeptide samples were analyzed on a mass spectrometer (LTQ Or­
bitrap Velos; Thermo Fisher Scientific) equipped with a quaternary pump 
(Accela 600; Thermo Fisher Scientific) and a microautosampler (Famos; LC 
Packings). Nanospray tips were hand pulled using 100­µm inner diameter 
fused­silica tubing and packed with 0.5 cm of Magic C4 resin (5 µm and 
100 Å; Michrom BioResources) followed by 20 cm of Maccel C18AQ 
resin (3 µm and 200 Å; Nest Group). Peptides were separated using a 
gradient of 3–28% ACN in 0.125% FA over 70 min with an in­column flow 
rate of 300–500 nl/min.
Peptides  were  detected  using  a  data­dependent  top  20  MS2 
method. For each cycle, one full MS scan of mass per charge (m/z) = 
300–1,500 was acquired in the Orbitrap at a resolution of 60,000 at 
m/z = 400 with automatic gain control target = 10
6 and a maximum 
ion accumulation time of 500 ms. Each full scan was followed by the 
selection of the most intense ions, up to 20, for collision­induced disso­
ciation and MS2 analysis in the LTQ. An automatic gain control target 
of 2 × 10
3 and maximum ion accumulation time of 150 ms were used 
for MS2 scans. Ions selected for MS2 analysis were excluded from re­
analysis for 60 s. Precursor ions with charge = 1 or unassigned were 
excluded from selection for MS2 analysis. Lock mass, using atmospheric 
polydimethylsiloxane  (m/z  =  445.120025)  as  an  internal  standard, 
was used in all runs to calibrate Orbitrap MS precursor masses. For 
replicate 1, eight fractions were analyzed once each. For replicates 2 
and 3, sufficient material was recovered to shoot samples in duplicate 
for most fractions. For replicate 2, all nine fractions were analyzed in 
duplicate. For replicate 3, fractions 1–6 were analyzed in duplicate, 
whereas  fractions  7–9  were  analyzed  once.  For  protein  abundance 
analysis, 5% of each SCX fraction was removed before phosphopeptide 
enrichment, desalted on a Stage tip, resuspended in 5% FA, and ana­
lyzed in a single run for each fraction as described in the previous 
paragraphs for phosphopeptides but using a 90­min gradient of 3–25% 
buffer B and 75­s dynamic exclusion.
cell cycle at a reduced size, despite having reduced levels of 
Cln3 (Hall et al., 1998; Newcomb et al., 2003). If poor nutri­
ents reduce the threshold, lower levels of Cln3 would be re­
quired for cell cycle entry. Further analysis of the targets of 
PP2A
Rts1, as well as the signals that control PP2A
Rts1, will 
likely  provide  important  new  clues  to  how  cell  division  is 
linked to cell growth.
Materials and methods
Yeast strains, culture conditions, and plasmids
All strains are in the W303 background (leu2-3,112 ura3-1 can1-100 
ade2-1 his3-11,15 trp1-1 GAL+ ssd1-d2). The genotypes of the strains 
used for this study are listed in Table 2. Full­length CLN3 was expressed 
from the GAL1 promoter using the integrating plasmid pDK93A (GAL1-
CLN3 URA3). One­step PCR­based gene replacement was used for con­
struction of deletions and epitope tags at the endogenous locus. Strains 
that contain GAL1-CDC20 strains were made by genetic crosses (Bhoite 
et al., 2001) or by using a PCR­based approach to integrate the GAL1 
promoter in front of the endogenous CDC20 gene in the appropriate back­
ground. Cells were grown in YEPD media (1% yeast extract, 2% peptone, 
and 2% dextrose) supplemented with 40 mg/liter adenine or in YEP media 
(1% yeast extract and 2% peptone) supplemented with an added carbon 
source, as noted.
Preparation of samples for MS
To prepare samples for MS, wild­type and rts1 cells containing CLN2-
3×HA were grown in YEPD medium overnight at room temperature. Cells 
were arrested in G1 with a mating pheromone and released from the arrest 
at 30°C at an OD600 of 0.7. Samples were taken for Cln2­3×HA Western 
blots every 10 min after the arrest, which were used to confirm that samples 
for MS were taken just before Cln2 could be detected by Western blotting. 
At 20 min after release, 25 ml of the culture was harvested by centrifuging 
95 s at 3,800 rpm, and 1 ml of ice­cold lysis buffer (8 M urea, 75 mM 
NaCl, 50 mM Tris­HCl, pH 8.0, 50 mM NaF, 50 mM ­glycerophosphate, 
1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, and 1 mM 
PMSF) was added to the cells and used to transfer them to a wide­bottom, 
1.6­ml screw­top tube. The cells were pelleted again, and the supernatant 
was removed. Approximately 0.5 ml of glass beads was added, and the 
cells were frozen in liquid nitrogen. The cells were lysed by the addition of 
750 µl lysis buffer followed by bead beating using a disrupter (Multibeater­
8; BioSpec) at top speed for three cycles of 1 min, each followed by a   
1­min incubation on ice to avoid overheating of the lysates. Samples were 
centrifuged at 13,000 rpm for 15 s, and the supernatants were transferred 
to fresh 1.6­ml tubes, which were centrifuged at 13,000 rpm for 10 min at 
4°C. The supernatants from this spin were transferred to fresh 1.6­ml tubes 
and frozen in liquid nitrogen. This procedure yielded 0.7 ml of extract at 
2–5 mg/ml.
Disulfide bonds were reduced by adding DTT to a final concen­
tration of 2.5 mM and incubating at 56°C for 40 min. The extract was   
allowed to cool to room temperature, and the reduced cysteines were 
alkylated by adding iodoacetamide to 7.5 mM and incubating for 40 min 
in the dark at room temperature. Alkylation was quenched with an addi­
tional 5 mM DTT.
Peptide digestion and labeling by reductive dimethylation
Proteins were diluted 2.5­fold into 25 mM (final concentration) Tris­HCl,   
pH 8.8, and digested by the addition of lysyl endopeptidase (Lys­C; Wako 
Chemicals USA) to a final concentration of 10 ng/µl with gentle agitation 
overnight at room temperature. Digested peptides were acidified by the 
addition of neat formic acid (FA) to a 1% final concentration, and the resul­
tant precipitate was pelleted by centrifuging for 2 min at 21,000 g. The   
supernatants were loaded onto prewet 200 mg tC18, reverse­phase, solid­
phase extraction cartridges (Waters). The columns were washed with 6 ml 
of 1% FA followed by 3 ml phosphate/citrate buffer (227 mM Na2HPO4 
and 86 mM NaH2C6H5O7, pH 5.5). Peptides were labeled by reductive di­
methylation (Boersema et al., 2009) with 6 ml of “light” reductive dimethyl­
ation  reaction  mix  (0.8%  formaldehyde  [Sigma­Aldrich]  and  120  mM 
NaCNBH3 [Sigma­Aldrich] in phosphate/citrate buffer) or with 6 ml of 
“heavy” reductive dimethylation reaction mix (0.8% D2­formaldehyde [Iso­
tec] and 120 mM NaCNBD3 [C/D/N Isotopes, Inc.] in phosphate/citrate 373 PP2A
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To synchronize cells at metaphase, cells containing GAL1-CDC20 
were grown overnight in YEP media containing 2% raffinose and 2% galac­
tose. Cells were arrested by washing into media containing 2% raffinose 
and incubated at room temperature for 4 h. Cells were released from the 
metaphase arrest by adding 2% galactose and were then shifted to 30°C for 
Western blotting experiments or 25°C for CLN3 mRNA analysis.
For induced expression experiments, cells were grown overnight in 
YEP medium containing 2% glycerol and 2% ethanol. Expression of genes 
from the GAL1 promoter was induced by addition of 2% galactose, and 
the cells were shifted to 30°C.
For time courses using analogue­sensitive alleles, cells were grown 
overnight in YEPD without adenine. The adenine analogue inhibitor 1NM­
PP1 was added to log phase cells at a final concentration of 25 µM, and 
the cells were then shifted to 30°C.
To analyze log phase cells, cultures were grown in YEPD, YEPD + 
2% galactose, or YEPD + 2% glycerol/ethanol overnight at room tempera­
ture. 1.6 ml of cells at an OD600 of 0.6 were collected and centrifuged at 
13,000 rpm for 30 s, the supernatant was removed, and 250 µl of glass 
beads were added before freezing in liquid nitrogen.
Western blotting
To collect samples for Western blotting, 1.6­ml samples were collected   
at each time point and centrifuged at 13,000 rpm for 30 s. The super­
natant was removed, and 250 µl of glass beads were added before freez­
ing in liquid nitrogen. Cells were lysed using 140 µl of sample buffer   
(65 mM Tris­HCl, pH 6.8, 3% SDS, 10% glycerol, 50 mM NaF, 100 mM   
­glycerophosphate, 5% 2­mercaptoethanol, and bromophenol blue). 
PMSF was added to the sample buffer to 2 mM immediately before use. Cells 
were lysed in a Multibeater­8 at top speed for 2 min. The samples were re­
moved and centrifuged for 15 s at 13,000 rpm in a microfuge and placed 
in boiling water for 5 min. After boiling, the samples were centrifuged for 
5 min at 13,000 rpm and loaded on an SDS polyacrylamide gel.
To assay phosphorylation of Ace2 serine 122, cells were grown 
overnight in YEPD media at room temperature to OD600 = 0.6. Cells from 
50 ml of culture were pelleted, resuspended in 1 ml of ice­cold 50 mM Hepes, 
pH 7.6, and pelleted in a wide­bottomed 1.6­ml screw top tube. Cells were 
lysed by bead beating in 600 µl lysis buffer (50 mM Tris­HCl, pH 7.5,150 mM 
NaCl,1% Triton X­100, 10% glycerol, 120 mM ­glycerophosphate, and   
2 mM sodium orthovanadate) containing 2 mM PMSF, 1 mM leupeptin,   
1 mM chymostatin, 1 mM pepstatin, and 20 μM cantharidin. Ace2­3×HA 
was immunoprecipitated with mouse monoclonal 12CA5 antibody. West­
ern blots were probed with rabbit anti–phospho­S122 antibody (gift of E. 
Weiss, Northwestern University, Evanston, IL) as previously described, ex­
cept that the antibody was used at a dilution of 1:30,000 in TBST (10 
mM Tris­Cl, pH 7.5, 100 mM NaCl, and 0.1% Tween 20) containing 4% 
BSA (Mazanka and Weiss, 2010).
SDS­PAGE was performed as previously described (Harvey et al., 
2005). Gels were run at a constant current of 20 mA. For Ace2, Clb2, 
and Cln3, electrophoresis was performed on 10% polyacrylamide gels 
until a 29­kD prestained marker ran to the bottom of the gel. Protein was 
transferred to nitrocellulose membranes for 1.5 h at 800 mA at 4°C in   
a transfer tank (TE22; Hoeffer) in buffer containing 20 mM Tris base, 150 mM 
glycine, and 20% methanol. Blots were probed overnight at 4°C with   
affinity­purified rabbit polyclonal antibodies raised against Ace2, Clb2, 
or the HA peptide or mouse monoclonal antibody against the HA pep­
tide. Cln3­6×HA blots were probed with the 12CA5 anti­HA monoclonal 
antibody. All blots were probed with an HRP­conjugated donkey anti–
rabbit secondary antibody (GE Healthcare) or HRP­conjugated donkey 
anti–mouse antibody for 45–90 min at room temperature. Secondary 
antibodies were detected via chemiluminescence with Advansta ECL or 
Quantum reagents.
RNA analysis
qRT­PCR was used to measure CLN3 mRNA levels as described using 
RPR1 RNA as the internal control (CLN3 primers: 5­CAGCGATCAG­
CGAATACAATAA­3  and  5­TGATAATGAACCGCGAGGAA­3;  RPR1 
control primers: 5­CACCTATGGGCGGGTTATCAG­3 and 5­CCTAG­
GCCGAACTCCGTGA­3; Voth et al., 2007). Northern blotting probes 
for CLN3 and ACT1 RNA were made using gel­purified PCR products (CLN3 
oligonucleotides: 5­GCGGGATCCATGGCCATATTGAAGGATAC­3 and 
5­GCGGAGCTCTCAGCGAGTTTTCTTGAGGT­3; ACT1 oligonucleotides: 
5­TCATACCTTCTACAACGAATTGAGA­3 and 5­ACACTTCATGATG­
GAGTTGTAAGT­3). Probes were labeled using the DNA labeling kit 
(Megaprime; GE Healthcare). RNA for Northern blotting was isolated as 
previously described (Cross and Tinkelenberg, 1991; Kellogg and Murray, 
Peptide identification and filtering
MS2 spectra were searched using SEQUEST v.28 (revision 13; Eng et al., 
1994) against a composite database containing the translated sequences 
of all predicted open reading frames of Saccharomyces cerevisiae (Sac-
charomyces Genome Database, downloaded 10/30/2009) and its re­
versed complement using the following parameters: a precursor mass 
tolerance of ±20 ppm; 1.0­D product ion mass tolerance; Lys­C digestion; 
up to two missed cleavages; static modifications of carbamidomethylation 
on cysteine (57.0214) and dimethyl adducts (28.0313) on lysine and pep­
tide amino termini; and dynamic modifications for methionine oxidation 
(15.9949), heavy dimethylation (6.0377) on lysine and peptide amino 
termini, and phosphate (79.9663) on serine, threonine, and tyrosine for 
phosphopeptide­enriched samples.
Peptide spectral matches were filtered to a 1% false discovery rate 
(FDR) using the target decoy strategy (Elias and Gygi, 2007) combined 
with linear discriminant analysis (Huttlin et al., 2010) using several differ­
ent parameters, including Xcorr, Cn’, precursor mass error, observed ion 
charge state, and predicted solution charge state. Linear discriminant mod­
els were calculated for each LC­MS/MS run using peptide matches to for­
ward and reversed protein sequences as positive and negative training 
data. Peptide spectral matches within each run were sorted in descending 
order by a discriminant score and filtered to a 1% FDR as revealed by the 
number of decoy sequences remaining in the dataset. The data were fur­
ther filtered to control protein level FDRs. Peptides from all fractions in each 
experiment were combined and assembled into proteins. Protein scores 
were derived from the product of all linear discriminant analysis peptide 
probabilities, sorted by rank, and filtered to 1% FDR as described for pep­
tides. The FDR of the remaining peptides fell dramatically after protein filter­
ing. Remaining peptide matches to the decoy database were removed 
from the final dataset.
For inclusion in quantitative calculations, peptides were required to 
have a minimum signal­to­noise ratio of ≥5 or a maximum value ≥10 for 
heavy and light species. Protein abundance ratios were calculated using 
the median log2 ratio of all peptides for each protein. This was performed 
independently for each of the three biological replicate experiments, and 
only those proteins for which we quantified more than two unique peptides 
were retained in the dataset (Table S1). Ratios were normalized to recenter 
the distribution at 1:1 (log2 = 0). Phosphopeptide ratios were adjusted for 
changes in protein abundance where possible using the corresponding 
protein ratio from the matched experiment. However, corrections were only 
applied if protein levels were available for all experiments in which the 
phosphosite was quantified (7,230 of 9,255 quantified sites were cor­
rected for protein level abundance and 3,983 of 5,159 high quality sites 
quantified in two or more replicates). We note that although we were un­
able to normalize all phosphorylation site quantifications to protein level 
changes, the vast majority of proteins undergo almost no change in abun­
dance between the two samples (log2 ratio SD = 0.32); thus, most uncor­
rected ratios are unlikely to be significantly skewed. Phosphorylation site 
ratios were calculated from the median of all quantified phosphopeptides 
harboring each site in each replicate.
Phosphorylation site localization analysis was performed using 
the Ascore algorithm (Beausoleil et al., 2006). These values appear in 
Table S2.
Cell cycle time courses and log phase cells
To ensure that protein loading was normalized in time course experiments, 
we determined ODs of cultures from each strain that yield equal amounts 
of extracted protein. This was necessary because large cells (i.e., rts1 
cells) or clumpy cells (i.e., ace2 cells) scatter light differently. Samples of 
cultures from each strain at varying ODs were harvested, and the cells 
were lysed by bead beating. The protein concentration in extracts from 
each strain was then measured to determine which ODs yield comparable 
amounts of extracted protein. We found that ODs of 0.6 (wild type), 0.8 
(rts1), 0.5 (ace2), and 0.5 (rts1 ace2) yielded protein concentrations 
with differences of less than twofold. We also used multiple background 
bands in Western blots to ensure that protein loading between strains and 
individual samples was normalized.
To synchronize cells in G1 with a mating pheromone, cells were 
grown to log phase in YEPD overnight at room temperature before syn­
chronization. Cells at an OD600 of 0.6 were arrested in G1 by addition 
of 0.5 µg/ml of  factor for 3.5 h at room temperature. Cells were re­
leased into a synchronous cell cycle by washing 3× with fresh YEPD 
prewarmed to 30°C. Time courses were performed at 30°C unless other­
wise noted. To prevent cells from reentering the cell cycle,  factor was 
added back at 65 min after release.JCB • VOLUME 204 • NUMBER 3 • 2014   374 
Immunoaffinity purifications and in vitro assays
Immunoaffinity purification of Ace2­3×HA and Cbk1­3×HA was performed 
in the presence of 1 M KCl as previously described with the following 
changes (Mortensen et al., 2002). Affinity beads were prepared by bind­
ing 0.6 mg anti­HA antibody to 0.5 ml protein A beads overnight at 4°C. 
14 g of frozen cell powder was resuspended in 30 ml lysis buffer (50 mM 
Hepes­KOH, pH 7.6, 1 M KCL, 1 mM EGTA, 1 mM MgCl2, 0.25% Tween 
20, and 5% glycerol) containing 1 mM PMSF by stirring at 4°C for 15 min. 
The cell extract was centrifuged at 40,000 rpm for 1 h. The elution buffer 
contained 50 mM Hepes­KOH, pH 7.6, 250 mM KCl, 1 mM EGTA, 1 mM 
MgCl2, 5% glycerol, and 0.5 mg/ml HA dipeptide. The Ace2­3×HA was 
treated with  phosphatase before elution.
To test whether Cbk1 directly phosphorylates Ace2, purified Ace2 
and Cbk1 were mixed in the presence of 1 mM ATP and kinase assay buffer 
(50 mM Hepes­KOH, pH 7.6, 1 mM MgCl2, 1 mM DTT, 5% glycerol, 
0.05% Tween 20, and 10 ng/µl BSA). The reactions were incubated for 
30 min at 30°C and then quenched with 4× SDS­PAGE sample buffer (260 mM 
Tris­HCl, pH 6.8, 12% SDS, 40% glycerol, and 0.04% bromophenol blue). 
The samples were loaded onto a 10% SDS­PAGE gel, which was trans­
ferred to nitrocellulose and probed with anti­Ace2. Similar approaches 
were used to test the effects of purified Cdk1/Clb2 (Harvey et al., 2011).
Centrifugal elutriation
Cells for elutriation were grown overnight at 30°C in YEP medium contain­
ing 2% glycerol and 2% ethanol to increase the fraction of very small un­
budded cells. Centrifugal elutriation was performed as previously described 
(Futcher, 1999; McCusker et al., 2012). In brief, cells were elutriated at 
4°C in a centrifuge (J6­MI; Beckman Coulter) with a rotor (JE­5.0; Beckman 
Coulter) at 2,700 rpm. Small unbudded cells were released into fresh 
YEPD media at 25°C, and samples were taken at 10­min intervals.
Online supplemental material
Fig. S1 shows an example of phosphopeptide quantification data obtained by 
proteome­wide MS. Fig. S2 shows loading controls for Fig. 6 (A, C, and D). 
Table S1 lists relative protein abundance measurements for all quantified 
proteins, including average values as well as those for each biological rep­
licate. Table S2 lists all sites detected by MS listed by protein and site along 
with quantification data for all three replicates. Table S3 lists all phospho­
peptides that passed peptide and protein target decoy filtering along with 
key SEQUEST search parameters and Ascore site localization data. Table 
S4 lists all sites that showed significantly increased phosphorylation in 
rts1 cells. Table S5 lists all sites that showed significantly decreased phos­
phorylation in rts1 cells. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201309119/DC1.
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hyde for 20 min at room temperature. Cross­linking was quenched with 
0.125 M glycine for 5 min, and cells were washed twice with TBS. Cell 
pellets were resuspended in lysis buffer (0.1% deoxycholic acid, 1 mM 
EDTA, 50 mM Hepes, pH 7.5, 140 mM NaCl, and 1% Triton X­100 sup­
plemented with 0.8 mM DTT and protease inhibitors) and were lysed with 
0.5­mm zirconia beads (BioSpec) in a cell disrupter (Mini­Beadbeater; Bio­
Spec). After centrifugation, the pellet was washed with lysis buffer and 
sonicated to a shearing size of <500 nucleotides using a bath sonicator 
(Biorupter XL; Diagenode). The sonicated material was centrifuged, and the 
supernatant containing the chromatin was quantitated by Bradford assay.
Immunoprecipitations were performed overnight at 4°C using 500–
700 µg of chromatin, 4A6 monoclonal antibody to the Myc epitope (EMD 
Millipore), and Pan–Mouse Dyna Beads IgG (Invitrogen). The beads were 
washed twice with lysis buffer, twice with high salt buffer (lysis buffer with 
500 mM NaCl), twice with LiCl buffer (0.5% deoxycholic acid, 1 mM EDTA, 
250 mM LiCl, 0.5% NP­40, and 10 mM Tris­HCl, pH 8.0), and once with 
TE. Cross­links were reversed overnight in elution buffer (10 mM EDTA, 1% 
SDS, and 50 mM Tris­HCl, pH 8.0) at 65°C. DNA was purified using the 
PCR purification kit (QIAquick; QIAGEN). Quantitative PCR reactions were 
performed using a detection system (LightCycler480 II; Roche). A standard 
curve representing a range of concentrations of input samples was used   
for quantitating the amount of product for each sample with each primer 
set. All ChIP samples were normalized to corresponding input control sam­
ples, to a genomic reference region on chromosome I, and to a genetically 
identical untagged strain as a control. (ChIP primers for the CLN3 promoter 
region: 5­TACATTCTGTGCTGGCGACC­3, 5­TTTGAGCACAGCGTTT­
GGTTG­3, 5­ATTCGTCTCGTTTGAAC­GCTTG­3, and 5­GCCAAGC­
GTTCAAACGAGAC­3; ChIP primers for the chromosome I control region: 
5­GTTTATAGCGGGCATTATGCGTAGATCAG­3  and  5­GTTCCTCTAG­
AATTTTTCCACTCGCACATTC­3).
Analysis of cell size, bud emergence, and cell proliferation
Triplicate cell cultures were grown overnight to log phase at room temperature 
in YEPD or YEP containing 2% galactose. A 0.9­ml sample of each culture was 
fixed with 100 µl of 37% formaldehyde for 1 h and then washed twice with 
PBS + 0.04% sodium azide + 0.02% Tween 20. Cell size was measured using 
a Coulter counter (Channelizer Z2; Beckman Coulter) as previously described 
(Jorgensen et al., 2002). In brief, 150 µl of fixed culture was diluted in 20 ml 
diluent (Isoton II; Beckman Coulter) and sonicated for 20 s before cell sizing. 
Each plot is the average of three independent experiments in which three inde­
pendent samples were analyzed per strain. The size of elutriated cells was 
measured in the same manner except that the cells were not sonicated. The 
percentage of budded cells was measured by counting the number of small 
unbudded cells over a total of ≥200 cells using a phase­contrast microscope 
(Carl Zeiss) with a 40×/0.65 NA objective (Carl Zeiss).
To assay the rate of cell proliferation on plates, cells were grown 
overnight in YEPD at room temperature and adjusted to an OD600 of 1.0. 
Fivefold serial dilutions were spotted onto YEPD or YEP containing 2% ga­
lactose and incubated at 30 or 37°C. To assay the growth rate in liquid 
cultures, eight independent cultures of each strain were grown overnight, 
and each was diluted 100­fold in inoculating 0.2­ml cultures in a 100­well 
plate where growth was monitored in a Bioscreen C apparatus (Growth 
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